Van Belleghem, Jonas D.; Dąbrowska, Krystyna; Vaneechoutte, Mario; Barr, Jeremy J.; Bollyky, Paul L. (2018). ”Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System”. Viruses 11(1): 10. doi:10.3390/v11010010.
Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah (2010). ”Phage Therapy in Clinical Practice: Treatment of Human Infections”. Current Pharmaceutical Biotechnology 11 (1): sid. 69–86. doi:10.2174/138920110790725401.
Lin, Derek M.; Koskella, Britt; Lin, Henry C. (2017). ”Phage therapy: An alternative to antibiotics in the age of multi-drug resistance”. World Journal of Gastrointestinal Pharmacology and Therapeutics 8 (3): sid. 162–173. doi:10.4292/wjgpt.v8.i3.162.
Housby, John N.; Mann, Nicholas H. (2009). ”Phage Therapy”. Drug Discovery Today 14 (11-12): sid. 536-540. doi:10.1016/j.drudis.2009.03.006.
Barr, Jeremy J. (2017). ”A bacteriophages journey through the human body”. Immunological Reviews 279 (1): sid. 106–122. doi:10.1111/imr.12565.
Azam, Haeruman; Tanji, Yasunori (2019). ”Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy”. Applied Microbiology and Biotechnology 103 (5): sid. 2121–2131. doi:10.1007/s00253-019-09629-x.
Poullain, Virginie; Gandon, Sylvain; Brockhurst, Michael A.; Buckling, Angus; Hochberg, Michael E. (2008). ”The Evolution of Specificity in Evolving and Coevolving Antagonistic Interactions Between a Bacteria and Its Phage”. Evolution 62 (1): sid. 1–11. doi:10.1111/j.1558-5646.2007.00260.x.
Bakhshinejad, Babak; Ghiasvand, Saeedeh (2017). ”Bacteriophages in the human gut: Our fellow travelers throughout life and potential biomarkers of heath or disease”. Virus Research 240: sid. 47–55. doi:10.1016/j.virusres.2017.07.013.
Blum, Hubert E. (2017). ”The human microbiome”. Advances in Medical Sciences 62 (2): sid. 414–420. doi:10.1016/j.advms.2017.04.005.
Hyman, Paul (2019). ”Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth”. Pharmaceuticals 12 (1). doi:10.3390/ph12010035.
Cisek, Agata A.; Dąbrowska, Iwona; Gregorczyk, Karolina P.; Wyżewski, Zbigniew (2017). ”Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages”. Current Microbiology 74 (2): sid. 277–283. doi:10.1007/s00284-016-1166-x.
Azeredo, Joana; Kluskens, Leon D.; Costa, Ana R.; Nobrega, Franklin L. (2015). ”Revisiting phage therapy: new applications for old resources”. Trends in Microbiology 23 (4): sid. 185–191. doi:10.1016/j.tim.2015.01.006.
Loc-Carrillo, Catherine; Abedon, Stephen T. (2011). ”Pros and cons of phage therapy”. Bacteriophage 1 (2): sid. 111–114. doi:10.4161/bact.1.2.14590.
Kropinski, Andrew M. (2006). ”Phage Therapy: Everything Old is New Again”. The Canadian Journal of Infectious Diseases & Medical Microbiology 17 (5): sid. 297–306. PMID 18382643.